nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—ovarian cancer—uterine cancer	0.617	1	CtDrD
Melphalan—SLC22A3—Progesterone—uterine cancer	0.249	1	CbGbCtD
Melphalan—SLC7A5—myometrium—uterine cancer	0.00259	0.082	CbGeAlD
Melphalan—SLC7A5—epithelium—uterine cancer	0.00203	0.0644	CbGeAlD
Melphalan—SLC7A5—uterine cervix—uterine cancer	0.00202	0.0638	CbGeAlD
Melphalan—SLC7A5—smooth muscle tissue—uterine cancer	0.00196	0.062	CbGeAlD
Melphalan—SLC7A5—decidua—uterine cancer	0.00192	0.0608	CbGeAlD
Melphalan—SLC7A5—endometrium—uterine cancer	0.00182	0.0577	CbGeAlD
Melphalan—SLC7A5—mammalian vulva—uterine cancer	0.00176	0.0559	CbGeAlD
Melphalan—SLC7A5—uterus—uterine cancer	0.00168	0.0532	CbGeAlD
Melphalan—SLC22A3—myometrium—uterine cancer	0.00161	0.0509	CbGeAlD
Melphalan—SLC7A5—female reproductive system—uterine cancer	0.00151	0.0478	CbGeAlD
Melphalan—SLC7A5—female gonad—uterine cancer	0.00137	0.0435	CbGeAlD
Melphalan—SLC7A5—vagina—uterine cancer	0.00137	0.0433	CbGeAlD
Melphalan—SLC22A3—uterine cervix—uterine cancer	0.00125	0.0396	CbGeAlD
Melphalan—SLC22A3—smooth muscle tissue—uterine cancer	0.00122	0.0385	CbGeAlD
Melphalan—SLC22A3—renal system—uterine cancer	0.00117	0.0371	CbGeAlD
Melphalan—SLC22A3—endometrium—uterine cancer	0.00113	0.0358	CbGeAlD
Melphalan—SLC22A3—mammalian vulva—uterine cancer	0.00109	0.0347	CbGeAlD
Melphalan—SLC22A3—female reproductive system—uterine cancer	0.000938	0.0297	CbGeAlD
Melphalan—SLC7A5—lymph node—uterine cancer	0.000884	0.028	CbGeAlD
Melphalan—SLC22A3—female gonad—uterine cancer	0.000853	0.027	CbGeAlD
Melphalan—SLC22A3—vagina—uterine cancer	0.000848	0.0269	CbGeAlD
Melphalan—SLC22A3—lymph node—uterine cancer	0.000549	0.0174	CbGeAlD
Melphalan—Ibuprofen—CXCL8—uterine cancer	0.000402	1	CrCbGaD
Melphalan—Hepatitis—Dactinomycin—uterine cancer	0.00024	0.00234	CcSEcCtD
Melphalan—Infection—Progesterone—uterine cancer	0.00024	0.00234	CcSEcCtD
Melphalan—Cardiac arrest—Etoposide—uterine cancer	0.000239	0.00233	CcSEcCtD
Melphalan—Tachycardia—Progesterone—uterine cancer	0.000236	0.0023	CcSEcCtD
Melphalan—Skin disorder—Progesterone—uterine cancer	0.000235	0.00229	CcSEcCtD
Melphalan—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000232	0.00226	CcSEcCtD
Melphalan—Skin ulcer—Doxorubicin—uterine cancer	0.000231	0.00225	CcSEcCtD
Melphalan—Anorexia—Progesterone—uterine cancer	0.00023	0.00224	CcSEcCtD
Melphalan—Feeling hot—Doxorubicin—uterine cancer	0.000229	0.00223	CcSEcCtD
Melphalan—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000228	0.00222	CcSEcCtD
Melphalan—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000228	0.00222	CcSEcCtD
Melphalan—Neoplasm malignant—Epirubicin—uterine cancer	0.000227	0.00222	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000227	0.00221	CcSEcCtD
Melphalan—Hypotension—Progesterone—uterine cancer	0.000226	0.0022	CcSEcCtD
Melphalan—Flushing—Dactinomycin—uterine cancer	0.000223	0.00217	CcSEcCtD
Melphalan—Extravasation—Epirubicin—uterine cancer	0.000223	0.00217	CcSEcCtD
Melphalan—Amenorrhoea—Epirubicin—uterine cancer	0.000221	0.00215	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00022	0.00214	CcSEcCtD
Melphalan—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00213	CcSEcCtD
Melphalan—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00213	CcSEcCtD
Melphalan—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000218	0.00212	CcSEcCtD
Melphalan—Paraesthesia—Progesterone—uterine cancer	0.000217	0.00211	CcSEcCtD
Melphalan—Dyspnoea—Progesterone—uterine cancer	0.000215	0.0021	CcSEcCtD
Melphalan—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000214	0.00209	CcSEcCtD
Melphalan—Bronchospasm—Etoposide—uterine cancer	0.000214	0.00208	CcSEcCtD
Melphalan—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000214	0.00208	CcSEcCtD
Melphalan—Dyspepsia—Progesterone—uterine cancer	0.000213	0.00207	CcSEcCtD
Melphalan—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000213	0.00207	CcSEcCtD
Melphalan—Alopecia—Dactinomycin—uterine cancer	0.000212	0.00207	CcSEcCtD
Melphalan—Neoplasm malignant—Doxorubicin—uterine cancer	0.00021	0.00205	CcSEcCtD
Melphalan—Decreased appetite—Progesterone—uterine cancer	0.00021	0.00205	CcSEcCtD
Melphalan—Hyperuricaemia—Epirubicin—uterine cancer	0.000209	0.00204	CcSEcCtD
Melphalan—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000209	0.00203	CcSEcCtD
Melphalan—Gastrointestinal disorder—Progesterone—uterine cancer	0.000209	0.00203	CcSEcCtD
Melphalan—Fatigue—Progesterone—uterine cancer	0.000208	0.00203	CcSEcCtD
Melphalan—Pain—Progesterone—uterine cancer	0.000207	0.00201	CcSEcCtD
Melphalan—Pancytopenia—Etoposide—uterine cancer	0.000206	0.00201	CcSEcCtD
Melphalan—Extravasation—Doxorubicin—uterine cancer	0.000206	0.00201	CcSEcCtD
Melphalan—Ulcer—Epirubicin—uterine cancer	0.000205	0.002	CcSEcCtD
Melphalan—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000205	0.00199	CcSEcCtD
Melphalan—Amenorrhoea—Doxorubicin—uterine cancer	0.000205	0.00199	CcSEcCtD
Melphalan—Neutropenia—Etoposide—uterine cancer	0.000203	0.00198	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0002	0.00194	CcSEcCtD
Melphalan—Blood uric acid increased—Epirubicin—uterine cancer	0.000198	0.00193	CcSEcCtD
Melphalan—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00192	CcSEcCtD
Melphalan—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000195	0.0019	CcSEcCtD
Melphalan—Hepatocellular injury—Epirubicin—uterine cancer	0.000194	0.00189	CcSEcCtD
Melphalan—Hyperuricaemia—Doxorubicin—uterine cancer	0.000194	0.00189	CcSEcCtD
Melphalan—Anaemia—Dactinomycin—uterine cancer	0.000193	0.00188	CcSEcCtD
Melphalan—Injection site reaction—Epirubicin—uterine cancer	0.000193	0.00188	CcSEcCtD
Melphalan—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000193	0.00188	CcSEcCtD
Melphalan—Urticaria—Progesterone—uterine cancer	0.000192	0.00187	CcSEcCtD
Melphalan—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00019	0.00185	CcSEcCtD
Melphalan—Ulcer—Doxorubicin—uterine cancer	0.00019	0.00185	CcSEcCtD
Melphalan—Neuropathy peripheral—Etoposide—uterine cancer	0.00019	0.00185	CcSEcCtD
Melphalan—Cystitis noninfective—Epirubicin—uterine cancer	0.00019	0.00185	CcSEcCtD
Melphalan—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000189	0.00184	CcSEcCtD
Melphalan—Stomatitis—Etoposide—uterine cancer	0.000189	0.00184	CcSEcCtD
Melphalan—Jaundice—Etoposide—uterine cancer	0.000189	0.00184	CcSEcCtD
Melphalan—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000189	0.00184	CcSEcCtD
Melphalan—Cystitis—Epirubicin—uterine cancer	0.000188	0.00183	CcSEcCtD
Melphalan—Leukopenia—Dactinomycin—uterine cancer	0.000187	0.00182	CcSEcCtD
Melphalan—Skin exfoliation—Epirubicin—uterine cancer	0.000185	0.00181	CcSEcCtD
Melphalan—Hepatobiliary disease—Etoposide—uterine cancer	0.000183	0.00179	CcSEcCtD
Melphalan—Blood uric acid increased—Doxorubicin—uterine cancer	0.000183	0.00178	CcSEcCtD
Melphalan—Neuropathy—Epirubicin—uterine cancer	0.000182	0.00178	CcSEcCtD
Melphalan—Hepatocellular injury—Doxorubicin—uterine cancer	0.00018	0.00175	CcSEcCtD
Melphalan—Injection site reaction—Doxorubicin—uterine cancer	0.000179	0.00174	CcSEcCtD
Melphalan—Myalgia—Dactinomycin—uterine cancer	0.000178	0.00174	CcSEcCtD
Melphalan—Hypersensitivity—Progesterone—uterine cancer	0.000178	0.00173	CcSEcCtD
Melphalan—Mouth ulceration—Epirubicin—uterine cancer	0.000176	0.00171	CcSEcCtD
Melphalan—Neoplasm—Epirubicin—uterine cancer	0.000176	0.00171	CcSEcCtD
Melphalan—Bladder pain—Epirubicin—uterine cancer	0.000176	0.00171	CcSEcCtD
Melphalan—Cystitis noninfective—Doxorubicin—uterine cancer	0.000176	0.00171	CcSEcCtD
Melphalan—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000174	0.00169	CcSEcCtD
Melphalan—Cystitis—Doxorubicin—uterine cancer	0.000174	0.00169	CcSEcCtD
Melphalan—Asthenia—Progesterone—uterine cancer	0.000173	0.00169	CcSEcCtD
Melphalan—Urinary tract disorder—Etoposide—uterine cancer	0.000172	0.00167	CcSEcCtD
Melphalan—Skin exfoliation—Doxorubicin—uterine cancer	0.000172	0.00167	CcSEcCtD
Melphalan—Pruritus—Progesterone—uterine cancer	0.000171	0.00167	CcSEcCtD
Melphalan—Oedema—Dactinomycin—uterine cancer	0.000171	0.00166	CcSEcCtD
Melphalan—Urethral disorder—Etoposide—uterine cancer	0.000171	0.00166	CcSEcCtD
Melphalan—Infection—Dactinomycin—uterine cancer	0.00017	0.00165	CcSEcCtD
Melphalan—Neuropathy—Doxorubicin—uterine cancer	0.000169	0.00164	CcSEcCtD
Melphalan—Thrombocytopenia—Dactinomycin—uterine cancer	0.000167	0.00163	CcSEcCtD
Melphalan—Diarrhoea—Progesterone—uterine cancer	0.000165	0.00161	CcSEcCtD
Melphalan—Anorexia—Dactinomycin—uterine cancer	0.000163	0.00159	CcSEcCtD
Melphalan—Bladder pain—Doxorubicin—uterine cancer	0.000162	0.00158	CcSEcCtD
Melphalan—Neoplasm—Doxorubicin—uterine cancer	0.000162	0.00158	CcSEcCtD
Melphalan—Mouth ulceration—Doxorubicin—uterine cancer	0.000162	0.00158	CcSEcCtD
Melphalan—Flushing—Etoposide—uterine cancer	0.000161	0.00157	CcSEcCtD
Melphalan—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000161	0.00157	CcSEcCtD
Melphalan—Immune system disorder—Etoposide—uterine cancer	0.000157	0.00153	CcSEcCtD
Melphalan—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000157	0.00153	CcSEcCtD
Melphalan—Mediastinal disorder—Etoposide—uterine cancer	0.000157	0.00153	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000156	0.00152	CcSEcCtD
Melphalan—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000155	0.00151	CcSEcCtD
Melphalan—Alopecia—Etoposide—uterine cancer	0.000154	0.0015	CcSEcCtD
Melphalan—Vomiting—Progesterone—uterine cancer	0.000154	0.0015	CcSEcCtD
Melphalan—Renal failure acute—Epirubicin—uterine cancer	0.000153	0.00149	CcSEcCtD
Melphalan—Rash—Progesterone—uterine cancer	0.000152	0.00148	CcSEcCtD
Melphalan—Dermatitis—Progesterone—uterine cancer	0.000152	0.00148	CcSEcCtD
Melphalan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00015	0.00146	CcSEcCtD
Melphalan—Decreased appetite—Dactinomycin—uterine cancer	0.000148	0.00145	CcSEcCtD
Melphalan—Fatigue—Dactinomycin—uterine cancer	0.000147	0.00143	CcSEcCtD
Melphalan—Pain—Dactinomycin—uterine cancer	0.000146	0.00142	CcSEcCtD
Melphalan—Nausea—Progesterone—uterine cancer	0.000144	0.0014	CcSEcCtD
Melphalan—Hyponatraemia—Epirubicin—uterine cancer	0.000142	0.00138	CcSEcCtD
Melphalan—Renal failure acute—Doxorubicin—uterine cancer	0.000141	0.00138	CcSEcCtD
Melphalan—Anaemia—Etoposide—uterine cancer	0.00014	0.00136	CcSEcCtD
Melphalan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00136	CcSEcCtD
Melphalan—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000138	0.00134	CcSEcCtD
Melphalan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000138	0.00134	CcSEcCtD
Melphalan—Leukopenia—Etoposide—uterine cancer	0.000136	0.00132	CcSEcCtD
Melphalan—Cardiac arrest—Epirubicin—uterine cancer	0.000134	0.00131	CcSEcCtD
Melphalan—Cough—Etoposide—uterine cancer	0.000132	0.00129	CcSEcCtD
Melphalan—Convulsion—Etoposide—uterine cancer	0.000131	0.00128	CcSEcCtD
Melphalan—Hyponatraemia—Doxorubicin—uterine cancer	0.000131	0.00128	CcSEcCtD
Melphalan—Liver function test abnormal—Epirubicin—uterine cancer	0.00013	0.00127	CcSEcCtD
Melphalan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00013	0.00127	CcSEcCtD
Melphalan—Chest pain—Etoposide—uterine cancer	0.000129	0.00126	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000128	0.00125	CcSEcCtD
Melphalan—Hypersensitivity—Dactinomycin—uterine cancer	0.000126	0.00123	CcSEcCtD
Melphalan—Cardiac arrest—Doxorubicin—uterine cancer	0.000124	0.00121	CcSEcCtD
Melphalan—Anaphylactic shock—Etoposide—uterine cancer	0.000124	0.0012	CcSEcCtD
Melphalan—Infection—Etoposide—uterine cancer	0.000123	0.0012	CcSEcCtD
Melphalan—Asthenia—Dactinomycin—uterine cancer	0.000123	0.00119	CcSEcCtD
Melphalan—Thrombocytopenia—Etoposide—uterine cancer	0.000121	0.00118	CcSEcCtD
Melphalan—Tachycardia—Etoposide—uterine cancer	0.000121	0.00118	CcSEcCtD
Melphalan—Liver function test abnormal—Doxorubicin—uterine cancer	0.00012	0.00117	CcSEcCtD
Melphalan—Skin disorder—Etoposide—uterine cancer	0.00012	0.00117	CcSEcCtD
Melphalan—Anorexia—Etoposide—uterine cancer	0.000118	0.00115	CcSEcCtD
Melphalan—Diarrhoea—Dactinomycin—uterine cancer	0.000117	0.00114	CcSEcCtD
Melphalan—Pancytopenia—Epirubicin—uterine cancer	0.000116	0.00113	CcSEcCtD
Melphalan—Hypotension—Etoposide—uterine cancer	0.000116	0.00113	CcSEcCtD
Melphalan—Neutropenia—Epirubicin—uterine cancer	0.000114	0.00111	CcSEcCtD
Melphalan—Paraesthesia—Etoposide—uterine cancer	0.000111	0.00108	CcSEcCtD
Melphalan—Dyspnoea—Etoposide—uterine cancer	0.00011	0.00107	CcSEcCtD
Melphalan—Vomiting—Dactinomycin—uterine cancer	0.000109	0.00106	CcSEcCtD
Melphalan—Rash—Dactinomycin—uterine cancer	0.000108	0.00105	CcSEcCtD
Melphalan—Decreased appetite—Etoposide—uterine cancer	0.000107	0.00105	CcSEcCtD
Melphalan—Pancytopenia—Doxorubicin—uterine cancer	0.000107	0.00104	CcSEcCtD
Melphalan—Gastrointestinal disorder—Etoposide—uterine cancer	0.000107	0.00104	CcSEcCtD
Melphalan—Fatigue—Etoposide—uterine cancer	0.000107	0.00104	CcSEcCtD
Melphalan—Neuropathy peripheral—Epirubicin—uterine cancer	0.000107	0.00104	CcSEcCtD
Melphalan—Stomatitis—Epirubicin—uterine cancer	0.000106	0.00103	CcSEcCtD
Melphalan—Jaundice—Epirubicin—uterine cancer	0.000106	0.00103	CcSEcCtD
Melphalan—Pain—Etoposide—uterine cancer	0.000106	0.00103	CcSEcCtD
Melphalan—Neutropenia—Doxorubicin—uterine cancer	0.000105	0.00103	CcSEcCtD
Melphalan—Hepatobiliary disease—Epirubicin—uterine cancer	0.000103	0.001	CcSEcCtD
Melphalan—Nausea—Dactinomycin—uterine cancer	0.000101	0.000988	CcSEcCtD
Melphalan—Neuropathy peripheral—Doxorubicin—uterine cancer	9.85e-05	0.00096	CcSEcCtD
Melphalan—Urticaria—Etoposide—uterine cancer	9.82e-05	0.000957	CcSEcCtD
Melphalan—Haemoglobin—Epirubicin—uterine cancer	9.8e-05	0.000955	CcSEcCtD
Melphalan—Stomatitis—Doxorubicin—uterine cancer	9.8e-05	0.000954	CcSEcCtD
Melphalan—Jaundice—Doxorubicin—uterine cancer	9.8e-05	0.000954	CcSEcCtD
Melphalan—Hepatitis—Epirubicin—uterine cancer	9.75e-05	0.00095	CcSEcCtD
Melphalan—Haemorrhage—Epirubicin—uterine cancer	9.75e-05	0.00095	CcSEcCtD
Melphalan—Urinary tract disorder—Epirubicin—uterine cancer	9.63e-05	0.000938	CcSEcCtD
Melphalan—Connective tissue disorder—Epirubicin—uterine cancer	9.58e-05	0.000934	CcSEcCtD
Melphalan—Urethral disorder—Epirubicin—uterine cancer	9.56e-05	0.000931	CcSEcCtD
Melphalan—Hepatobiliary disease—Doxorubicin—uterine cancer	9.51e-05	0.000926	CcSEcCtD
Melphalan—Hypersensitivity—Etoposide—uterine cancer	9.11e-05	0.000887	CcSEcCtD
Melphalan—Haemoglobin—Doxorubicin—uterine cancer	9.07e-05	0.000883	CcSEcCtD
Melphalan—Flushing—Epirubicin—uterine cancer	9.05e-05	0.000882	CcSEcCtD
Melphalan—Haemorrhage—Doxorubicin—uterine cancer	9.02e-05	0.000879	CcSEcCtD
Melphalan—Hepatitis—Doxorubicin—uterine cancer	9.02e-05	0.000879	CcSEcCtD
Melphalan—Urinary tract disorder—Doxorubicin—uterine cancer	8.91e-05	0.000868	CcSEcCtD
Melphalan—Asthenia—Etoposide—uterine cancer	8.87e-05	0.000864	CcSEcCtD
Melphalan—Connective tissue disorder—Doxorubicin—uterine cancer	8.87e-05	0.000864	CcSEcCtD
Melphalan—Urethral disorder—Doxorubicin—uterine cancer	8.85e-05	0.000862	CcSEcCtD
Melphalan—Immune system disorder—Epirubicin—uterine cancer	8.81e-05	0.000858	CcSEcCtD
Melphalan—Mediastinal disorder—Epirubicin—uterine cancer	8.79e-05	0.000856	CcSEcCtD
Melphalan—Pruritus—Etoposide—uterine cancer	8.75e-05	0.000852	CcSEcCtD
Melphalan—Arrhythmia—Epirubicin—uterine cancer	8.71e-05	0.000849	CcSEcCtD
Melphalan—Alopecia—Epirubicin—uterine cancer	8.62e-05	0.000839	CcSEcCtD
Melphalan—Diarrhoea—Etoposide—uterine cancer	8.46e-05	0.000824	CcSEcCtD
Melphalan—Flushing—Doxorubicin—uterine cancer	8.38e-05	0.000816	CcSEcCtD
Melphalan—Immune system disorder—Doxorubicin—uterine cancer	8.15e-05	0.000794	CcSEcCtD
Melphalan—Mediastinal disorder—Doxorubicin—uterine cancer	8.13e-05	0.000792	CcSEcCtD
Melphalan—Arrhythmia—Doxorubicin—uterine cancer	8.06e-05	0.000785	CcSEcCtD
Melphalan—Alopecia—Doxorubicin—uterine cancer	7.97e-05	0.000777	CcSEcCtD
Melphalan—Vomiting—Etoposide—uterine cancer	7.86e-05	0.000766	CcSEcCtD
Melphalan—Anaemia—Epirubicin—uterine cancer	7.85e-05	0.000764	CcSEcCtD
Melphalan—Rash—Etoposide—uterine cancer	7.79e-05	0.000759	CcSEcCtD
Melphalan—Dermatitis—Etoposide—uterine cancer	7.79e-05	0.000758	CcSEcCtD
Melphalan—Leukopenia—Epirubicin—uterine cancer	7.6e-05	0.00074	CcSEcCtD
Melphalan—Cough—Epirubicin—uterine cancer	7.41e-05	0.000722	CcSEcCtD
Melphalan—Convulsion—Epirubicin—uterine cancer	7.36e-05	0.000717	CcSEcCtD
Melphalan—Nausea—Etoposide—uterine cancer	7.34e-05	0.000715	CcSEcCtD
Melphalan—Anaemia—Doxorubicin—uterine cancer	7.26e-05	0.000707	CcSEcCtD
Melphalan—Myalgia—Epirubicin—uterine cancer	7.23e-05	0.000704	CcSEcCtD
Melphalan—Chest pain—Epirubicin—uterine cancer	7.23e-05	0.000704	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.18e-05	0.000699	CcSEcCtD
Melphalan—Leukopenia—Doxorubicin—uterine cancer	7.03e-05	0.000685	CcSEcCtD
Melphalan—Anaphylactic shock—Epirubicin—uterine cancer	6.93e-05	0.000675	CcSEcCtD
Melphalan—Oedema—Epirubicin—uterine cancer	6.93e-05	0.000675	CcSEcCtD
Melphalan—Infection—Epirubicin—uterine cancer	6.88e-05	0.000671	CcSEcCtD
Melphalan—Cough—Doxorubicin—uterine cancer	6.86e-05	0.000668	CcSEcCtD
Melphalan—Convulsion—Doxorubicin—uterine cancer	6.81e-05	0.000663	CcSEcCtD
Melphalan—Thrombocytopenia—Epirubicin—uterine cancer	6.78e-05	0.000661	CcSEcCtD
Melphalan—Tachycardia—Epirubicin—uterine cancer	6.76e-05	0.000659	CcSEcCtD
Melphalan—Skin disorder—Epirubicin—uterine cancer	6.73e-05	0.000656	CcSEcCtD
Melphalan—Chest pain—Doxorubicin—uterine cancer	6.69e-05	0.000651	CcSEcCtD
Melphalan—Myalgia—Doxorubicin—uterine cancer	6.69e-05	0.000651	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.64e-05	0.000647	CcSEcCtD
Melphalan—Anorexia—Epirubicin—uterine cancer	6.61e-05	0.000643	CcSEcCtD
Melphalan—Hypotension—Epirubicin—uterine cancer	6.48e-05	0.000631	CcSEcCtD
Melphalan—Anaphylactic shock—Doxorubicin—uterine cancer	6.41e-05	0.000625	CcSEcCtD
Melphalan—Oedema—Doxorubicin—uterine cancer	6.41e-05	0.000625	CcSEcCtD
Melphalan—Infection—Doxorubicin—uterine cancer	6.37e-05	0.00062	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.31e-05	0.000615	CcSEcCtD
Melphalan—Thrombocytopenia—Doxorubicin—uterine cancer	6.28e-05	0.000611	CcSEcCtD
Melphalan—Tachycardia—Doxorubicin—uterine cancer	6.26e-05	0.00061	CcSEcCtD
Melphalan—Skin disorder—Doxorubicin—uterine cancer	6.23e-05	0.000607	CcSEcCtD
Melphalan—Paraesthesia—Epirubicin—uterine cancer	6.22e-05	0.000606	CcSEcCtD
Melphalan—Dyspnoea—Epirubicin—uterine cancer	6.18e-05	0.000602	CcSEcCtD
Melphalan—Anorexia—Doxorubicin—uterine cancer	6.11e-05	0.000595	CcSEcCtD
Melphalan—Dyspepsia—Epirubicin—uterine cancer	6.1e-05	0.000594	CcSEcCtD
Melphalan—Decreased appetite—Epirubicin—uterine cancer	6.02e-05	0.000587	CcSEcCtD
Melphalan—Hypotension—Doxorubicin—uterine cancer	5.99e-05	0.000584	CcSEcCtD
Melphalan—Gastrointestinal disorder—Epirubicin—uterine cancer	5.98e-05	0.000583	CcSEcCtD
Melphalan—Fatigue—Epirubicin—uterine cancer	5.97e-05	0.000582	CcSEcCtD
Melphalan—Pain—Epirubicin—uterine cancer	5.93e-05	0.000577	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.84e-05	0.000569	CcSEcCtD
Melphalan—Paraesthesia—Doxorubicin—uterine cancer	5.76e-05	0.000561	CcSEcCtD
Melphalan—Dyspnoea—Doxorubicin—uterine cancer	5.72e-05	0.000557	CcSEcCtD
Melphalan—Dyspepsia—Doxorubicin—uterine cancer	5.64e-05	0.00055	CcSEcCtD
Melphalan—Decreased appetite—Doxorubicin—uterine cancer	5.57e-05	0.000543	CcSEcCtD
Melphalan—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.54e-05	0.000539	CcSEcCtD
Melphalan—Fatigue—Doxorubicin—uterine cancer	5.53e-05	0.000538	CcSEcCtD
Melphalan—Urticaria—Epirubicin—uterine cancer	5.5e-05	0.000536	CcSEcCtD
Melphalan—Pain—Doxorubicin—uterine cancer	5.48e-05	0.000534	CcSEcCtD
Melphalan—Hypersensitivity—Epirubicin—uterine cancer	5.11e-05	0.000497	CcSEcCtD
Melphalan—Urticaria—Doxorubicin—uterine cancer	5.09e-05	0.000496	CcSEcCtD
Melphalan—Asthenia—Epirubicin—uterine cancer	4.97e-05	0.000484	CcSEcCtD
Melphalan—Pruritus—Epirubicin—uterine cancer	4.9e-05	0.000478	CcSEcCtD
Melphalan—Diarrhoea—Epirubicin—uterine cancer	4.74e-05	0.000462	CcSEcCtD
Melphalan—Hypersensitivity—Doxorubicin—uterine cancer	4.72e-05	0.00046	CcSEcCtD
Melphalan—Asthenia—Doxorubicin—uterine cancer	4.6e-05	0.000448	CcSEcCtD
Melphalan—Pruritus—Doxorubicin—uterine cancer	4.54e-05	0.000442	CcSEcCtD
Melphalan—Vomiting—Epirubicin—uterine cancer	4.41e-05	0.000429	CcSEcCtD
Melphalan—Diarrhoea—Doxorubicin—uterine cancer	4.39e-05	0.000427	CcSEcCtD
Melphalan—Rash—Epirubicin—uterine cancer	4.37e-05	0.000426	CcSEcCtD
Melphalan—Dermatitis—Epirubicin—uterine cancer	4.37e-05	0.000425	CcSEcCtD
Melphalan—Nausea—Epirubicin—uterine cancer	4.12e-05	0.000401	CcSEcCtD
Melphalan—Vomiting—Doxorubicin—uterine cancer	4.08e-05	0.000397	CcSEcCtD
Melphalan—Rash—Doxorubicin—uterine cancer	4.04e-05	0.000394	CcSEcCtD
Melphalan—Dermatitis—Doxorubicin—uterine cancer	4.04e-05	0.000393	CcSEcCtD
Melphalan—Nausea—Doxorubicin—uterine cancer	3.81e-05	0.000371	CcSEcCtD
